Search
Descriptor English: Terlipressin
Descriptor Spanish: Terlipresina
Descriptor terlipresina
Entry term(s) Gly Gly Gly 8 Lys vasopresina
Gly-Gly-Gly-8-Lys-vasopresina
Glycylpressin
Glypressin
N-(alfa)-glicil-glicil-glicil-8-lisina vasopresina
TGLVP
remestyp
tri-Gly-8-Lys- vasopresina
triglicil lisina vasopresina
triglicil-(8-lisina)vasopresina
triglicilvasopresina
Scope note: Profármaco peptídico inactivo que se convierte lentamente en el organismo en lipresina. Se usa para controlar la hemorragia de las VARICES ESOFÁGICAS y para el tratamiento del SÍNDROME HEPATORRENAL.
Descriptor Portuguese: Terlipressina
Descriptor French: Terlipressine
Entry term(s): Glipressin
Gly Gly Gly 8 Lys vasopressin
Gly-Gly-Gly-8-Lys-vasopressin
Glycylpressin
Glypressin
N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin
Remestyp
TGLVP
Terlypressin
Triglycyl Lysine Vasopressin
Triglycyl-(8-lysine)vasopressin
Triglycylvasopressin
Vasopressin, tri-Gly-8-Lys-
tri-Gly-8-Lys- Vasopressin
Tree number(s): D06.472.699.631.692.781.400.675
D12.644.400.900.400.675
D12.644.456.925.480.750
D12.644.548.691.692.781.400.675
D12.776.631.650.937.400.675
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077585
Scope note: An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
DE drug effects
DF deficiency
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antihypertensive Agents
Vasoconstrictor Agents
Registry Number: 7Z5X49W53P
CAS Type 1 Name: N-(N- (N-glycylglycyl)glycyl)-L-lysinevasopressin
Public MeSH Note: 2019; TERLIPRESSIN was indexed under LYPRESSIN/analogs & derivatives 1976-2018
History Note: 2019 (1976)
DeCS ID: 57693
Unique ID: D000077585
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/04/09
Terlipressin - Preferred
Concept UI M0058831
Scope note An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME.
Preferred term Terlipressin
Entry term(s) Glipressin
Glycylpressin
Glypressin
TGLVP
Terlypressin
Triglycyl Lysine Vasopressin
Triglycylvasopressin
Triglycyl-(8-lysine)vasopressin - Narrower
Concept UI M000640976
Preferred term Triglycyl-(8-lysine)vasopressin
Entry term(s) Gly Gly Gly 8 Lys vasopressin
Gly-Gly-Gly-8-Lys-vasopressin
N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin
Vasopressin, tri-Gly-8-Lys-
tri-Gly-8-Lys- Vasopressin
Remestyp - Narrower
Concept UI M0360130
Preferred term Remestyp



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey